Roflumilast
NDC 68382-624, Roflumilast, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-624
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208303
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-624 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-624-31 | 68382062431 | 1 BLISTER PACK in 1 CARTON (68382-624-31) / 28 TABLET in 1 BLISTER PACK |
| 68382-624-83 | 68382062483 | 2 BLISTER PACK in 1 CARTON (68382-624-83) / 10 TABLET in 1 BLISTER PACK (68382-624-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/84145572-f320-4c3f-ab29-bd9f6c18746cNADAC price for package 68382062431
GET /v1/drugs/nadac/68382062431NADAC price for package 68382062483
GET /v1/drugs/nadac/68382062483
Use it
Look up 68382-624 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-624 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-624. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.